Symbiotic.blue
PrivateLast Round
Pre Seed
Jun 19, 2025
Company Overview
Symbiotic.blue operates in Healthcare & Life Sciences and is based in London. It was founded in 2025.
Symbiotic.blue is a biotechnology company that develops an artificial intelligence-driven drug discovery platform by combining generative AI with brain-inspired methodologies.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology, Medical AI, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Subscription SaaS
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Symbiotic.blue Comparables
Compare Symbiotic.blue with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Harmonic Discovery | 84% | |
| PolarisQB | 82% | |
| Genesis Molecular AI | 76% |
For institutional investors. Book with your work email.
Symbiotic.blue Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Symbiotic.blue Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Symbiotic.blue's valuation, stock price, and market status.
Is Symbiotic.blue a public or private company?
Symbiotic.blue is a private company.
What is the current stock price of Symbiotic.blue?
Symbiotic.blue is a private company, so its shares have no public market price. Caplight tracks Symbiotic.blue's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Symbiotic.blue worth (valuation)?
Valuation information for Symbiotic.blue is not publicly available.
Can I buy Symbiotic.blue stock?
Symbiotic.blue shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Symbiotic.blue's last funding round?
Symbiotic.blue's most recent funding round was Pre Seed on June 19, 2025.
Who are the main investors in Symbiotic.blue?
Investor information for Symbiotic.blue is not publicly disclosed.
Will Symbiotic.blue IPO soon?
No public IPO plans have been announced for Symbiotic.blue.
How can I track Symbiotic.blue secondary market activity?
Caplight tracks bids, offers, and trades in Symbiotic.blue's shares on secondary markets.